Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up

<div>The Kaplan-Meier event-free survival curves in groups with NT-pro BNP (post) ≥cutoff point and CST (post) ≥cutoff point vs. NT-proBNP ≥cutoff point and CST (post) &lt; cutoff point for 24 months of follow-up.</div>

Disease Markers

fig3

Figure 3

Figure 3: Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up 